German CF Clinical Trial Network (CF-CTN)

To optimise the existing therapies and to develop new options, the German Cystic Fibrosis Association, Mukoviszidose e.V., wants to intensify the clinical research in the field of CF in terms of quality and quantity. In order to be able to offer the structures required for a quick and professional implementation of clinical studies (pharmaceutical and medical products, amongst others), the Mukoviszidose e.V. initiated the CF Clinical Trial Network (German CF-CTN).

More information... (PDF, 66KB)

“Quality Seal” Experts Committee in the CF-CTN for the evaluation of clinical studies

Mukoviszidose e.V. and its wholly-owned non-profit research subsidiary
Mukoviszidose Institut(e) gGmbH, Bonn, Germany, are committed to foster research and developing of new or improved options for the diagnosis or treatment of cystic fibrosis. Through the establishment of the experts committee in the German CF-Clinical Trial Network (CF-CTN), we aim at further supporting scientific progress.

More information... (PDF, 63 KB)

German CF Clinical Trial Network (CF-CTN)

“Quality Seal” Experts Committee in the CF-CTN for the evaluation of clinical studies

Wissenschaftler